NCT05795595
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05795595
Title A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors CRISPR Therapeutics AG
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Research Site 3 Duarte California 91010 United States Details
Research Site 7 Chicago Illinois 60637 United States Details
Research Site 6 Boston Massachusetts 02215 United States Details
Research Site 2 St Louis Missouri 63110 United States Details
Research Site 4 Durham North Carolina 27710 United States Details
Research Site 1 Nashville Tennessee 37203 United States Details
Research Site 5 Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field